Dan Nakano

10PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersExercise physiologyGastroenterology and hepatologyLiquid biopsiesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Mar 27, 2023
A low-intensity 10-min resistance exercise program that ameliorated hepatic fibrosis indices and altered G-CSF/IP-10/PDGF-BB in a patient with nonalcoholic fatty liver disease: A case report.

Ryuki Hashida, Dan Nakano, Hiroo Matsuse

|Sep 21, 2022
Hepatic expression of sodium-glucose cotransporter 2 (SGLT2) in patients with chronic liver disease.

Dan Nakano, Jun Akiba, Tsubasa Tsutsumi

|Apr 27, 2022
Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells.

Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi

|Mar 01, 2022
Atherosclerotic cardiovascular disease in non-metabolic nonalcoholic fatty liver disease.

Tsubasa Tsutsumi, Takumi Kawaguchi, Dan Nakano

|Sep 17, 2021
Association between the albumin-bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data-mining analysis.

Takumi Kawaguchi, Akihiro Honda, Yoichi Sugiyama

Pageof 2

Frequent Collaborators

9 joint publications

Takumi Kawaguchi

8 joint publications

Tsubasa Tsutsumi

4 joint publications

Hirokazu Takahashi

3 joint publications

Sakura Yamamura